Correction: Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials.

Correction: Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials.

Show other versions (1)

Bibliographic Details
Main Authors:	Yao Liu, Song Zhang, Dao-wei Li, Shu-juan Jiang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3692717

Similar Items

Correction: Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials
by: Yao Liu, et al.
Published: (2013-01-01)

Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials.
by: Yao Liu, et al.
Published: (2013-01-01)

Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome
by: Andrea Matucci, et al.
Published: (2018-05-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01)

Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion
by: Khodr Tello, et al.
Published: (2019-01-01)

Clinical efficacy of mepolizumab in the treatment of severe eosinophilic asthma in children
by: V. N. Drozdov, et al.
Published: (2020-11-01)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
by: Takanori Numata, et al.
Published: (2019-10-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
by: Terufumi Shimoda, et al.
Published: (2017-07-01)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
by: Pelaia C, et al.
Published: (2017-10-01)

Mepolizumab in the treatment of bronchial asthma in children
by: Yu. L. Mizernitskiy, et al.
Published: (2020-03-01)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
by: Menzella F, et al.
Published: (2016-06-01)

Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma – a systematic review and meta-analysis
by: Daniel P. Henriksen, et al.
Published: (2018-01-01)

Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma
by: Katrine Prætorius, et al.
Published: (2021-08-01)

Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials
by: Catherine Lemiere, et al.
Published: (2021-06-01)

Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies
by: Mi-Kyeong Kim, et al.
Published: (2021-03-01)

Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma
by: Diego Bagnasco, et al.
Published: (2020-08-01)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
by: Haldar P
Published: (2017-06-01)

The effect of mepolizumab, an anti-IL-5 monoclonal antibody, on eosinophilic otitis media associated with severe asthma
by: Yuki Maruyama, et al.
Published: (2020-08-01)

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
by: Menzella F, et al.
Published: (2015-10-01)

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial
by: Jacques Loretta, et al.
Published: (2011-10-01)

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
by: Manuel David Gil-Sierra, et al.
Published: (2019-11-01)

Self-Administered Mepolizumab in the Management of Severe Asthma: Usability and Patient Acceptance
by: Miyokawa R, et al.
Published: (2020-09-01)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
by: Diego Bagnasco, et al.
Published: (2021-02-01)

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
by: Peter G. Gibson, et al.
Published: (2021-06-01)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
by: Prazma CM, et al.
Published: (2021-06-01)

Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
by: Ravi Ranjan Pradhan, et al.
Published: (2019-01-01)

Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis.
by: Fa-Ping Wang, et al.
Published: (2016-01-01)

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
by: Gilda Varricchi, et al.
Published: (2017-01-01)

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
by: Mattia Giovannini, et al.
Published: (2019-11-01)

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
by: Rosalia Emma, et al.
Published: (2018-10-01)

Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs
by: Llanos JP, et al.
Published: (2020-01-01)

Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice
by: Olalla Montero-Pérez, et al.
Published: (2019-05-01)

Eosinophils depletion therapy for severe asthma management following favorable response to mepolizumab
by: Osamu Matsuno, et al.
Published: (2019-01-01)

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
by: Menzella F, et al.
Published: (2017-11-01)

Efficacy of <i>Lactobacillus</i> Administration in School-Age Children with Asthma: A Randomized, Placebo-Controlled Trial
by: Chian-Feng Huang, et al.
Published: (2018-11-01)

Analgesic Efficacy of Melatonin: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
by: Si Nae Oh, et al.
Published: (2020-05-01)

Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
by: Venkata Nagarjuna Maturu, et al.
Published: (2021-08-01)

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics
by: Mark C. Liu, et al.
Published: (2021-05-01)

Imaging for precision medicine: can V‐P SPECT measure mepolizumab response in asthma?
by: Vanessa M. McDonald, et al.
Published: (2021-03-01)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
by: Giovanna Elisiana Carpagnano, et al.
Published: (2021-03-01)